-
Open Enrollment Happening Now
Open Enrollment season is here -- your chance to secure quality health coverage through the Affordable Care Act.. Coloradans can visit connectforhealthco.com between now and January 15 to shop for plans. -
Preserving Colorado's Wild Places
The Colorado Wilderness Act of 2018 will protect approximately 740,000 acres of pristine land, helping secure our state's proud outdoor heritage and push back on the Trump Administration's assault on our last remaining wild places. -
Gun Violence Prevention
Americans are demanding that Congress pass sensible gun safety legislation. I'm continuing my ongoing work to make these reforms a reality, which will help keep all of our communities safer. -
Fulfilling DACA's Promise
President Trump's decision to rescind DACA is a crushing blow to more than 17,000 DREAMers in Colorado, but our fight isn't over. I will continue working to pass legislation, such as the Dream Act, that helps these young men and women remain in this country and achieve their American dream.
Home Page Tabs
Latest News
Washington, DC – Today, U.S. Reps. Diana DeGette (CO-01), Ed Perlmutter (CO-07), Jason Crow (CO-06) and Joe Neguse (CO-02) released a joint statement calling on Senate Republicans and President Trump to immediately act to end the partial government shutdown:
Washington, DC – Following is a statement from U.S. Rep. Diana DeGette (D-CO) on the president’s visit to McAllen, TX today. DeGette was one of two dozen House members who visited McAllen, TX in June to get a firsthand look at the situation on the ground there.
Washington, D.C. – U.S. Rep. Diana DeGette (D-CO) today led a bicameral group of more than 200 members of Congress in calling on the Trump administration to rescind a newly proposed rule that seeks to limit women’s access to abortion care.
Washington, DC – Congresswoman Diana DeGette (D-CO) released the following statement after President Trump’s televised Oval Office address to the nation:
Washington, DC – The U.S. House of Representatives today approved legislation aimed at improving and speeding up the federal Food and Drug Administration’s process for evaluating new over-the-counter (OTC) medications to determine whether they are safe enough to be sold to consumers without a prescription.